Business

The tariff block doesn’t affect auto levies, but some carmaker stocks are still rising

Automakers aren’t spared by a federal court’s decision on Wednesday to block a significant chunk of President Trump’s tariffs, but some are seeing stock gains anyway.

The Washington Post reports:

“Trump’s tariffs on specific products such as steel, aluminum and automobiles are not affected and are still in effect. Trump did not use the emergency powers to implement these levies, instead relying on a 1962 trade law. Typically, the commerce secretary or another government official has to investigate whether the imports affect national security under this law, so the process takes longer than using emergency powers.”

Stellantis, Nissan, and Toyota were all trading higher Thursday morning. Given that 25% tariffs on both vehicles and their parts are still on, the boosts are likely on the hopes that tariff easing in any direction will help free up consumer wallets and get them thinking about buying some cars.

Honda was also up more than 3%, while Ford and GM were flat.

Toyota, more specifically, is seeing a bit of a bump as panic buying fueled its second straight record sales month in April. Its US sales climbed 10% on the month.

More Business

See all Business
Galleri by GRAIL

Hims adds cancer detection test to Labs product

Its lab analysis product will be a central part of the company’s upcoming Super Bowl ad.

Walmart store entrance

Walmart joins the trillion-dollar club, becoming only the third non-tech American firm to do so

Shares have surged on rapid e-commerce growth, digital advertising, and new AI partnerships. Maybe Walmart isn’t that “offline” after all.

Senate Hearing Examines Competitive Impact Of Proposed Netflix-Warner Brothers Transaction

Netflix’s Sarandos: Big Tech is trying to “run away with the television business”

Netflix co-CEO Ted Sarandos addressed regulatory and industry fears around its merger plans.

Photo Illustration of Wegovy semaglutide tablets on a white background

How Novo Nordisk’s new Wegovy pill is transforming the weight-loss drug market

Telehealth executives and early prescription data show the Wegovy pill is pulling in new patients — and accelerating a shift toward cash-pay obesity care.

Latest Stories

Sherwood Media, LLC produces fresh and unique perspectives on topical financial news and is a fully owned subsidiary of Robinhood Markets, Inc., and any views expressed here do not necessarily reflect the views of any other Robinhood affiliate, including Robinhood Markets, Inc., Robinhood Financial LLC, Robinhood Securities, LLC, Robinhood Crypto, LLC, or Robinhood Money, LLC.